Clovis Oncology Inc (OTC Pink - Limited Information:CLVSQ)
| 0.0295 Delayed Data As of May 26 |  +0.0005 / +1.72%Today’s Change | 0.01 Today|||52-Week Range 3.25 | -44.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -352.9M | -349.1M | -346.4M | -368.0M | |
| Depreciation | 761.0K | 1.1M | 2.5M | 4.6M | ||
| Total Other Cash Flow | 104.8M | 121.2M | 151.8M | 52.6M | ||
| Funds From Operations | -276.2M | -258.6M | -195.3M | -310.8M | ||
| Funds From/For Other Operating Expenses | -23.1M | 8.1M | 65.6M | 55.2M | ||
| Net Cash Flow - Operating Activities | -253.1M | -266.7M | -260.9M | -366.0M | ||
| Investing | Increase In Investments | -392.5M | 0.00 | -263.5M | -500.0M | |
| Decrease In Investments | 141.0M | 200.0M | 213.5M | 300.0M | ||
| Capital Expenditures | -3.0M | -766.0K | -3.0M | -9.2M | ||
| Fixed Asset Disposal | -- | 65.0K | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -254.6M | 199.3M | -54.1M | -264.2M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | -245.0K | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 290.9M | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 304.5M | 5.2M | 562.1M | 97.9M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 35.0K | ||
| Net Cash Flow - Financing | 304.5M | 5.2M | 562.1M | 388.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -757.0K | -365.0K | 943.0K | -547.0K | |
| Net Change In Cash | -203.2M | -62.2M | 247.1M | -241.8M | ||
